{"id":"W4405584069","doi":"10.1002/ajh.27563","title":"Treatment Effectiveness of Venetoclax‐Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real‐World Study","year":2024,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Group for Research in Decision Analysis; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Incyte; Pharmacyclics; Genentech; Grifols; Galápagos; MEI Pharma; BeiGene; National Cancer Institute; AbbVie; Seagen; Gilead Sciences; Loxo Oncology; TG Therapeutics; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Venetoclax; Medicine; Chronic lymphocytic leukemia; Discontinuation; Ibrutinib; Internal medicine; Oncology; Clinical trial; Idelalisib; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006751836,0.0005547698,0.001325524,0.0007239635,0.0004094297,0.001803064,0.0006439409,0.001153643,0.003031289],"category_scores_gemma":[0.006504649,0.0001973155,0.001858931,0.001819721,0.001316015,0.001122447,0.0005305983,0.001940837,0.0004506284],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001726812,"about_ca_system_score_gemma":0.00101522,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001237485,"about_ca_topic_score_gemma":0.001418844,"domain_scores_codex":[0.9961204,0.002145308,0.0003665516,0.0005383675,0.0005596861,0.0002697071],"domain_scores_gemma":[0.9925816,0.002248787,0.003166339,0.0005589022,0.0004800476,0.0009642644],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4905362,0.02097334,0.1455862,0.005427317,0.01136527,0.0003676988,0.001116319,0.002699211,0.00389635,0.001266878,0.008398597,0.3083667],"study_design_scores_gemma":[0.1377227,0.2316218,0.5616823,0.003220558,0.01534941,0.001317763,0.00144616,0.002048787,0.001897711,0.0008831248,0.04250904,0.000300778],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9218275,0.06701722,0.0005746703,0.001126774,0.0002487676,0.000921318,0.00306933,0.00002542237,0.005189006],"genre_scores_gemma":[0.9787839,0.0147277,0.0006135516,0.001036458,0.0004752318,0.0007300295,0.002989468,0.00001594618,0.0006277429],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006751836,"threshold_uncertainty_score":0.03570753,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0186158064601441,"score_gpt":0.3424328678919236,"score_spread":0.3238170614317795,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}